Non-Formulary Use Criteria: 1. Consultation with BOP Chief psychiatrist and /or Central Office Transgender Clinical Management Team when providing transgender care
Formulary Restrictions:
UTILIZATION IN SEX-OFFENDOR TREATMENT REQUIRES WRITTEN MEDICAL DIRECTOR APPROVAL. REFER TO PARAPHILIA TREATMENT GUIDELINES